Logo 1 Logo 2

Clinical Trial Details

Trial ID: L6840
Source ID: NCT01718093
Associated Drug: Sitagliptin
Title: A Pilot Study to Assess the Glucose Lowering Effect of Metformin and Sitagliptin in Adolescents With Type 1 Diabetes
Acronym:
Status: COMPLETED
Study Results: NO
Results:
Conditions: Type 1 Diabetes
Interventions: DRUG: Sitagliptin|DRUG: Metformin|DRUG: Sitagliptin + Metformin
Outcome Measures: Primary: To determine the glucose lowering effect of metformin and sitagliptin alone and as combination therapy when used as adjuncts to insulin in adolescents with T1DM., Glucose concentrations and AUC glucose calculation, 10 - 15 weeks |
Sponsor/Collaborators: Sponsor: Baylor College of Medicine | Collaborators: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Gender: ALL
Age: CHILD, ADULT
Phases: PHASE4
Enrollment: 21
Study Type: INTERVENTIONAL
Study Designs: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Start Date: 2012-10
Completion Date: 2015-12
Results First Posted:
Last Update Posted: 2017-04-24
Locations: Baylor College of Medicine, Houston, Texas, 77030, United States
URL: https://clinicaltrials.gov/show/NCT01718093